Joshi Smita N, Gopalkrishna V, Kumar B Kishore, Dutta Soma, Nyaynirgune Pratima, Thakar Madhuri, Tripathy Srikanth, Mehendale Sanjay, Paranjape Ramesh
National AIDS Research Institute, Pune, India.
J Med Virol. 2005 Aug;76(4):470-5. doi: 10.1002/jmv.20385.
In view of the dual burden of HIV infection and cervical cancers in India, this study was undertaken to estimate the prevalence of Pap smear abnormalities and human papillomavirus infection among HIV-infected women. Consecutive HIV-infected women attending voluntary counseling testing clinics were enrolled. Written informed consent, demographic information, Pap smears, cervical swabs for HPV typing and a blood sample for CD4+ cell count were collected. Treatment for opportunistic and sexually transmitted infections and reproductive tract infections was provided. Women with Pap smear abnormality were referred for further intervention. Between January 2003 and May 2004, 287 HIV-infected women were enrolled. Pap smear abnormalities were seen in 6.3% women and were more common among women aged 30 and above (P=0.042) and those who had suffered from opportunistic infections (P=0.004). In multivariate analysis, Pap smear abnormalities were associated independently with opportunistic infections (P=0.02, AOR 3.8, 95% CI 1.2--11.5). Of the 100 random cervical specimens screened for HPV 16 and 18 genotypes, 33% (95 CI 23.9--43.1) were positive for HPV 16/18. Of the 122 patients who returned for a follow-up visit, 5 patients (4.1%) who did not have Pap smear abnormality at baseline, had developed Pap smear abnormality. The incidence of Pap smear abnormalities was 5.5 per 100 person year of follow-up. In order to prevent thousands of deaths due to cervical cancer in India, there is a need for strengthening the Pap smear screening program and HPV vaccine development.
鉴于印度存在艾滋病毒感染和宫颈癌的双重负担,开展了本研究以估计艾滋病毒感染女性中宫颈涂片异常和人乳头瘤病毒感染的患病率。连续纳入在自愿咨询检测诊所就诊的艾滋病毒感染女性。收集书面知情同意书、人口统计学信息、宫颈涂片、用于人乳头瘤病毒分型的宫颈拭子以及用于CD4+细胞计数的血样。提供机会性感染、性传播感染和生殖道感染的治疗。宫颈涂片异常的女性被转诊接受进一步干预。在2003年1月至2004年5月期间,纳入了287名艾滋病毒感染女性。6.3%的女性存在宫颈涂片异常,在30岁及以上女性(P = 0.042)和曾患机会性感染的女性中更为常见(P = 0.004)。在多变量分析中,宫颈涂片异常独立与机会性感染相关(P = 0.02,调整后比值比3.8,95%可信区间1.2 - 11.5)。在100份随机筛查人乳头瘤病毒16和18基因型的宫颈标本中,33%(95%可信区间23.9 - 43.1)人乳头瘤病毒16/18呈阳性。在122名返回进行随访的患者中,5名(4.1%)在基线时宫颈涂片无异常的患者出现了宫颈涂片异常。宫颈涂片异常的发病率为每100人年随访5.5例。为防止印度数千人死于宫颈癌,有必要加强宫颈涂片筛查计划和人乳头瘤病毒疫苗研发。